Zobrazeno 1 - 4 of 4 pro vyhledávání: '"Shuzo Tashima"'
1
Akademický článek
Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus
Autor: Seiichi Mawatari, Kotaro Kumagai, Kohei Oda, Kazuaki Tabu, Sho Ijuin, Kunio Fujisaki, Shuzo Tashima, Yukiko Inada, Hirofumi Uto, Akiko Saisyoji, Yasunari Hiramine, Masafumi Hashiguchi, Tsutomu Tamai, Takeshi Hori, Ohki Taniyama, Ai Toyodome, Haruka Sakae, Takeshi Kure, Kazuhiro Sakurai, Akihiro Moriuchi, Shuji Kanmura, Akio Ido
Publikováno v: PLoS ONE, Vol 17, Iss 1 (2022)
Background The features of hepatitis C virus patients with a sustained virologic response (SVR) who developed hepatocellular carcinoma (HCC) after direct-acting antiviral (DAA) therapy are unclear. Methods The study population included 1494 DAA-SVR p
Externí odkaz: https://doaj.org/article/a9d631c3572b48d2b03ea489655c1018
Zobrazit plný text záznamu
3
Sustained virologic response after eight weeks of treatment with sofosbuvir, ledipasvir, and ribavirin in a decompensated cirrhotic patient with hepatitis C virus genotype 1b
Autor: Kotaro Kumagai, Shuzo Tashima, Akio Ido, Kazuaki Tabu, Sho Ijuin, Tsutomu Tamai, Ai Kasai, Seiichi Mawatari, Kohei Oda, Akihiro Moriuchi, Ohki Taniyama
Publikováno v: Hepatology Research. 49:239-243
A 68-year-old Japanese man with decompensated cirrhosis due to hepatitis C virus (HCV) genotype 1b infection was treated with sofosbuvir (SOF; 400 mg/day), ledipasvir (LDV; 90 mg/day), and ribavirin (RBV; 400 mg/day). Before treatment, his Child-Pugh
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c57d36dd12a5991834bdbadd335620f5
https://doi.org/10.1111/hepr.13235
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje